Exploring FDA's Stance on LDTs & AI
Let’s Talk Medtech
00:00
Expectations and Challenges Ahead for FDA's Final Rule on LDTs & AI
Discussion on the expectations for the resolution of FDA's final rule, with predictions on publication, court challenges, Congress involvement, and the role of court deference to executive agencies.
Play episode from 22:42
Transcript
